• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2008 / August / 22 / Stoneridge No Help to Defendants in Bristol-Myers Case

Stoneridge No Help to Defendants in Bristol-Myers Case

By Securities Docket on August 22, 2008, 12:12 pm

Diving deeper into the recent federal court decision previously discussed here denying Bristol-Myers’ (BMY) motion to dismiss a securities class action, the New York Law Journal takes a look at the impact of the Supreme Court’s recent Stoneridge case on the decision. 

According to the article, one of the defendants sought to be dismissed from the suit under Stoneridge, which limited liability for securities fraud by actors who were “too remote” from investors.  Judge Paul A. Crotty, however, rejected that argument finding that “Bodnar made no public statements himself, but investors relied on his good faith in negotiating the Apotex settlement agreement and committing the company to its terms.”

Read the NY Law Journal article

Blog Widget by LinkWithin

Posted in Class Actions | Tagged Motion to Dismiss

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Ankura 260x250

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.